[1]
Chacón, K., Mendivelso, F., Gómez, O., González , C., Pinto, D., Yama, E., Moscoso, E., Acevedo, J., Bohórquez, L., Rincón, O., Ruiz, P., Espitia Malagón , R., Isaza, M., Aroca, G., Tovar, H., Luján, D., Rodríguez, M., Hamann, O. and Yomayusa, N. 2021. Comparative effectiveness and safety of Sodium-glucose Cotransporter-2 (SGLT2) inhibitors in type 2 diabetes mellitus: rapid review of systematic reviews and meta-analyzes. Revista Endocrino. 7, 4 (Jun. 2021), 222–234. DOI:https://doi.org/10.53853/encr.7.4.648.